ATE398131T1 - Kondensierte camptothecine als antitumormittel - Google Patents
Kondensierte camptothecine als antitumormittelInfo
- Publication number
- ATE398131T1 ATE398131T1 AT02803790T AT02803790T ATE398131T1 AT E398131 T1 ATE398131 T1 AT E398131T1 AT 02803790 T AT02803790 T AT 02803790T AT 02803790 T AT02803790 T AT 02803790T AT E398131 T1 ATE398131 T1 AT E398131T1
- Authority
- AT
- Austria
- Prior art keywords
- camptothecins
- condensed
- sup
- tumor agents
- identified
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01128361 | 2001-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE398131T1 true ATE398131T1 (de) | 2008-07-15 |
Family
ID=8179394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02803790T ATE398131T1 (de) | 2001-11-30 | 2002-11-25 | Kondensierte camptothecine als antitumormittel |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6825194B2 (OSRAM) |
| EP (1) | EP1480984B9 (OSRAM) |
| JP (1) | JP4305909B2 (OSRAM) |
| KR (1) | KR100895746B1 (OSRAM) |
| CN (1) | CN100338066C (OSRAM) |
| AT (1) | ATE398131T1 (OSRAM) |
| AU (1) | AU2002356720B2 (OSRAM) |
| BR (1) | BR0214615A (OSRAM) |
| CA (1) | CA2468824C (OSRAM) |
| DE (1) | DE60227113D1 (OSRAM) |
| ES (1) | ES2307830T3 (OSRAM) |
| GT (1) | GT200200250A (OSRAM) |
| HU (1) | HUP0500062A3 (OSRAM) |
| IL (1) | IL162058A0 (OSRAM) |
| MX (1) | MXPA04005185A (OSRAM) |
| MY (1) | MY136138A (OSRAM) |
| NO (1) | NO329005B1 (OSRAM) |
| NZ (1) | NZ533568A (OSRAM) |
| PA (1) | PA8558901A1 (OSRAM) |
| PE (1) | PE20030725A1 (OSRAM) |
| PL (1) | PL207510B1 (OSRAM) |
| RS (1) | RS51051B (OSRAM) |
| RU (1) | RU2299212C2 (OSRAM) |
| TW (1) | TWI258481B (OSRAM) |
| UA (1) | UA80409C2 (OSRAM) |
| UY (1) | UY27560A1 (OSRAM) |
| WO (1) | WO2003045952A2 (OSRAM) |
| ZA (1) | ZA200404522B (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1777611A (zh) * | 2003-02-21 | 2006-05-24 | 中外制药株式会社 | 制备六环喜树碱衍生物的方法 |
| MXPA06011679A (es) | 2004-04-09 | 2007-01-23 | Chugai Pharmaceutical Co Ltd | Novedosos profarmacos solubles en agua. |
| TW200744603A (en) * | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
| US20090118271A1 (en) * | 2005-10-19 | 2009-05-07 | Chugai Seiyaku Kabushiki Kaisha | Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug |
| RU2439073C1 (ru) * | 2010-07-13 | 2012-01-10 | Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУ ВПО "КубГТУ") | СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ИНДОЛИЗИНО[7,6-b]ИНДОЛА |
| EP3946464B1 (en) | 2019-03-29 | 2022-08-31 | MedImmune Limited | Compounds and conjugates thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4473692A (en) | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
| US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
| HU213136B (en) * | 1990-08-14 | 1997-02-28 | Kyorin Seiyaku Kk | Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them |
| JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
| JP3359955B2 (ja) * | 1992-07-16 | 2002-12-24 | 第一製薬株式会社 | 抗腫瘍剤 |
| GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
| US5663177A (en) * | 1995-05-31 | 1997-09-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
| WO1998035940A1 (en) | 1997-02-14 | 1998-08-20 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
| GB9715821D0 (en) * | 1997-07-25 | 1997-10-01 | Pharmacia & Upjohn Spa | Amidino-camptothecin derivatives |
-
2002
- 2002-11-25 AU AU2002356720A patent/AU2002356720B2/en not_active Ceased
- 2002-11-25 ES ES02803790T patent/ES2307830T3/es not_active Expired - Lifetime
- 2002-11-25 DE DE60227113T patent/DE60227113D1/de not_active Expired - Lifetime
- 2002-11-25 MX MXPA04005185A patent/MXPA04005185A/es active IP Right Grant
- 2002-11-25 CA CA2468824A patent/CA2468824C/en not_active Expired - Fee Related
- 2002-11-25 BR BR0214615-0A patent/BR0214615A/pt not_active IP Right Cessation
- 2002-11-25 IL IL16205802A patent/IL162058A0/xx not_active IP Right Cessation
- 2002-11-25 RS YUP-470/04A patent/RS51051B/sr unknown
- 2002-11-25 UA UA20040605013A patent/UA80409C2/uk unknown
- 2002-11-25 NZ NZ533568A patent/NZ533568A/en not_active IP Right Cessation
- 2002-11-25 JP JP2003547402A patent/JP4305909B2/ja not_active Expired - Fee Related
- 2002-11-25 PL PL370479A patent/PL207510B1/pl not_active IP Right Cessation
- 2002-11-25 EP EP02803790A patent/EP1480984B9/en not_active Expired - Lifetime
- 2002-11-25 WO PCT/EP2002/013216 patent/WO2003045952A2/en not_active Ceased
- 2002-11-25 HU HU0500062A patent/HUP0500062A3/hu unknown
- 2002-11-25 CN CNB028277465A patent/CN100338066C/zh not_active Expired - Fee Related
- 2002-11-25 AT AT02803790T patent/ATE398131T1/de not_active IP Right Cessation
- 2002-11-25 RU RU2004119841/04A patent/RU2299212C2/ru not_active IP Right Cessation
- 2002-11-25 KR KR1020047008223A patent/KR100895746B1/ko not_active Expired - Fee Related
- 2002-11-26 US US10/304,672 patent/US6825194B2/en not_active Expired - Fee Related
- 2002-11-27 TW TW091134463A patent/TWI258481B/zh not_active IP Right Cessation
- 2002-11-28 PE PE2002001148A patent/PE20030725A1/es not_active Application Discontinuation
- 2002-11-28 PA PA20028558901A patent/PA8558901A1/es unknown
- 2002-11-28 MY MYPI20024479A patent/MY136138A/en unknown
- 2002-11-29 GT GT200200250A patent/GT200200250A/es unknown
- 2002-11-29 UY UY27560A patent/UY27560A1/es not_active Application Discontinuation
-
2004
- 2004-06-08 ZA ZA200404522A patent/ZA200404522B/en unknown
- 2004-06-29 NO NO20042729A patent/NO329005B1/no not_active IP Right Cessation
- 2004-09-16 US US10/942,044 patent/US7109195B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004016516D1 (de) | Pyrimidin-2,4-dion-derivate als gonadotropin freisetzende hormon-rezeptor-antagonisten | |
| JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
| MXPA06000716A (es) | Derivados de quinolina y quinazolina que tienen afinidad hacia receptores del tipo 5ht1. | |
| NO20054404L (no) | 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon | |
| AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| EA200400466A1 (ru) | Производные пиперазина с антагонистической активностью к рецептору ccr1 | |
| DE602004020638D1 (de) | Pyrimidin-2,4-dion-derivate als gonadotropin freisetzende hormon-rezeptor-antagonisten | |
| ATE226208T1 (de) | 4-oxo-4,7-dihydro-thieno(2,3-b)pyridin-5- carboxamide als antivirale mittel | |
| DE60324544D1 (de) | Muskarin antagonisten | |
| ECSP055809A (es) | Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4 | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
| PT992509E (pt) | Novos derivados macrolidos | |
| EE200000472A (et) | Kasvajavastased toimeained | |
| EA200301203A1 (ru) | Новые соединения и композиции как ингибиторы катепсина | |
| EP1453506A4 (en) | Topoisomerase GIFT FUNDS | |
| ATE398131T1 (de) | Kondensierte camptothecine als antitumormittel | |
| DE60215637D1 (de) | Tri- und tetraaza-acenaphthylen-derivate als crf-rezeptor-antagonisten | |
| ATE324368T1 (de) | Heteroarylheteroalkylamin derivate und deren verwendung als inhibitoren der stickoxidsynthase | |
| AU2001263329A1 (en) | Crf receptor antagonists and methods relating thereto | |
| DE10310106A8 (de) | Substituierte Pyrido[1,2-a]pyrimidin-Verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |